Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. - Wikidata - wikimedia - TriplyDB

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

http://www.wikidata.org/entity/Q33530091

about

The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase A diverse range of gene products are effectors of the type I interferon antiviral response Restricting retrotransposons: a review Guardian of the Human Genome: Host Defense Mechanisms against LINE-1 Retrotransposition Foamy virus assembly with emphasis on pol encapsidation HIV restriction in quiescent CD4⁺ T cells IRAV (FLJ11286), an Interferon Stimulated Gene with Antiviral Activity Against Dengue Virus, Interacts with MOV10 Poliovirus-mediated disruption of cytoplasmic processing bodies HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus.Mov10 suppresses retroelements and regulates neuronal development and function in the developing brain.Host and viral determinants of Mx2 antiretroviral activity Virus-induced aggregates in infected cells.RNA helicases: emerging roles in viral replication and the host innate response.Mouse knockout models for HIV-1 restriction factors.HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells.HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep.HIV-1 suppressive sequences are modulated by Rev transport of unspliced RNA and are required for efficient HIV-1 production.Stem cell-based anti-HIV gene therapy.Function of a retrotransposon nucleocapsid protein Mini ways to stop a virus: microRNAs and HIV-1 replication Unraveling regulation and new components of human P-bodies through a protein interaction framework and experimental validation Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity.Antiretroviral restriction factors.Ty3 Retrotransposon Hijacks Mating Yeast RNA Processing Bodies to Infect New Genomes.Genome-Wide Search for Host Association Factors during Ovine Progressive Pneumonia Virus Infection Antiviral gene expression in psoriasis.Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10 New insights into HIV assembly and trafficking.Host restriction factors in retroviral infection: promises in virus-host interaction.Sequence requirements for localization and packaging of Ty3 retroelement RNA.Diversion of stress granules and P-bodies during viral infection.Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein.UPF1 is crucial for the infectivity of human immunodeficiency virus type 1 progeny virions.The MOV10 helicase inhibits LINE-1 mobility.Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells.

P2860

Q24294522-6E452990-C66F-4418-B353-A24E6E2DD0AB Q24611223-3D253D89-7872-497E-B612-566B46BE26DF Q24612444-5A18BFF1-C1CD-4085-9F2E-20CBD2C095EE Q24626018-DD350B79-8720-47BA-98D7-F7F6569A38CE Q26741496-145C2E44-03B0-4738-9822-7F678010DDEB Q26742086-9E51659B-DBFC-4C4F-B6A0-2E5DE439B6F4 Q26860084-2D926F43-CBC8-4B50-9769-F35473F236AC Q26995784-104DBDED-8191-4F69-A573-9E536BC3531D Q28733416-0394C7DD-1047-499C-8A57-AA4BFDF90A93 Q30155985-B3838A7B-D450-431C-9828-86F129712125 Q30634144-E5AE2EF7-7ED7-41CF-AA43-C64811E6934F Q32174293-17ECA4D4-B0CF-4858-A959-2C9D42D03BDE Q33900299-DA2C3704-FA94-41F6-BABB-67CB697C6748 Q34034603-77988066-630E-48F0-B636-35DF5940A492 Q34155934-B7FA688C-D2C9-47E5-AA24-24347BA88CEF Q34161853-683594D7-307C-4052-B18B-82E576422C34 Q34291663-9584B051-D748-4E72-A4A4-5E2511CF01AF Q34456088-FF5A5889-181E-4797-8A92-6541C454B9FB Q34511101-20E89FB1-5D42-4DCC-968A-1FA93A5F552B Q34516541-D1BCD5B2-FF0E-443F-B72D-E372813EBACB Q34769333-24168AEC-B142-4137-A57D-F9319A92D681 Q34775636-4AD28E7B-867F-49AF-B6D0-371379854CDA Q35055688-4D964CE9-ED43-4F49-A78E-8BBDBCD38479 Q35182650-A480A2C7-FD14-40D6-8575-E10906548444 Q35668775-AED9AA0A-BD73-446F-A086-1766639FA477 Q35686784-88186EA3-B47A-4302-B0C2-A869B7AA3EAC Q35793313-099503EE-5BD4-43CC-B252-1AAF336D0E5D Q35948010-B9B3AC82-D4B2-485A-931B-30C6D883A066 Q36086989-D00359C0-B815-463E-82BA-046536BAA08C Q36127858-6E814F06-ABB3-438C-8093-116588BC38DE Q36216069-84D81966-933C-4D74-B237-E2F525C3C4AB Q36307738-9ECA4444-055B-4337-B924-0F420CF5EA49 Q36548179-CF473315-D5F3-47C8-B7F4-16444F77AD64 Q36626099-7C8B01AD-8647-4953-B841-10B8054167B0 Q36727541-1FBE714A-3A87-4442-BA8C-3435588B142A Q36736357-934C5E21-801B-4459-A34F-363ECCCDAFE9 Q37123249-A9EFEB12-1F7C-4DAE-83F5-EF2351A066DE Q37175149-A7620CA9-73E6-4A76-A72D-D87BF0BE1A32 Q37252567-4030A95B-7A99-424A-9FC5-BD9F117B7DD7 Q37252793-28A071EE-2427-4FE4-ABAF-CA017D312CD7

P2860

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

http://www.wikidata.org/entity/Q33530091

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@ast

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@en

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@nl

type

label

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@ast

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@en

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@nl

prefLabel

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@ast

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@en

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@nl

P1433

Q33530091-20994610-AB64-4FEE-B142-40531A7BE375

P1476

Q33530091-C7030C58-7207-455F-BDE1-B11AE0AE306D

P2093

Q33530091-000BE0BD-CCA4-47D3-AE42-F23A2910E762

Q33530091-22B0735C-D69F-49E1-8F99-A9516EBF6BB5

Q33530091-3E4ED884-1614-4CCF-8394-B92FD819F0F6

Q33530091-4447ADDA-640D-4620-B1A6-28A78238FD5D

Q33530091-8D9D20E8-CEED-4E6D-B751-EF576CFF6A5F

Q33530091-9034211E-AFC8-4D09-9CCE-2F5522C2845B

Q33530091-BADDC10C-AF5F-4289-A07B-584F2B6346BB

P2860

Q33530091-016B9A7D-A632-446E-8070-FD32A8BF24B2

Q33530091-0477031F-45D6-407B-BAF7-594363B9675B

Q33530091-10824DD1-0090-4C63-8731-1C724623D6B4

Q33530091-1150E161-0FCB-4162-AD1E-4ACA81AA9BDC

Q33530091-1726179A-2F6F-4867-AC53-B46C92AA3313

Q33530091-17C1A7D2-1F03-4390-A76D-8BB0E9B016E3

Q33530091-2946C660-3434-42D5-81AE-43483B8E62EF

Q33530091-29A08A61-6761-49FD-AD31-97F1E69CF166

Q33530091-2CE086D8-9654-447A-A147-757288C7B602

Q33530091-31FCFB49-238B-4BC2-B889-F711AE52A55D

P304

Q33530091-24AFD182-C4D8-452B-B4A3-089013ADFE28

P31

Q33530091-2D5E7562-FC9E-4B52-8A35-F8BAF935B1E0

P356

Q33530091-C6C573E6-CA3C-43BC-9301-00D96C17370D

P407

Q33530091-8B8BD84B-7471-45CD-BAA1-6CB6A9824A24

P433

Q33530091-D42F2E0C-F815-4F04-B655-CFC79B50033E

P478

Q33530091-055ABD00-906D-41A8-B4F1-B581825B1603

P577

Q33530091-A9DAACB4-B142-4533-84DA-F170C5A5DE58

P5875

Q33530091-F79994C7-9C74-4120-B870-E494D39C4187

P698

Q33530091-41C60E47-2389-40F9-A6A7-06B41EFF184E

P932

Q33530091-212A0C24-19C3-4401-9D88-BD35989F2928

P356

JOURNAL.PONE.0009081

P1433

P1476

Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.

@en

P2093

Alok Mulky

http://www.w3.org/2001/XMLSchema#string

Derya Unutmaz

http://www.w3.org/2001/XMLSchema#string

KyeongEun Lee

http://www.w3.org/2001/XMLSchema#string

Lina Kozhaya

http://www.w3.org/2001/XMLSchema#string

Stephen A Rawlings

http://www.w3.org/2001/XMLSchema#string

Vineet N Kewalramani

http://www.w3.org/2001/XMLSchema#string

Vyacheslav Furtak

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of novel argonaute-associated proteins

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families.

MicroRNA silencing through RISC recruitment of eIF6

Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity

P bodies: at the crossroads of post-transcriptional pathways

SDE3 encodes an RNA helicase required for post-transcriptional gene silencing in Arabidopsis

The DEAD-box protein family of RNA helicases

Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection

P304

e9081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0009081

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41414705

http://www.w3.org/2001/XMLSchema#string

P698

20140200

http://www.w3.org/2001/XMLSchema#string

P932

2816699

http://www.w3.org/2001/XMLSchema#string